Spero Therapeutics Inc (SPRO) has fallen Thursday morning, with the stock falling -1.75% in pre-market trading to 1.12. SPRO's short-term technical score of 48 indicates that the stock has traded less bullishly over the last month than 52% of stocks on the market. In the Biotechnology industry, which ranks 119 out of 146 industries, the stock ranks higher than 61% of stocks. Spero Therapeutics Inc has remained neutral 0.00% over the past month, closing at $1.10 on October 19. During this period of time, the stock fell as low as $1.00 and as high as $1.29. SPRO has an average analyst recommendation of Strong Buy. The company has an average price target of $6.00.
SPRO has an Overall Score of 53. Find out what this means to you and get the rest of the rankings on SPRO!